Literature DB >> 23911405

Immature mouse granulocytic myeloid cells are characterized by production of ficolin-B.

Dorothea Weber-Steffens1, Katja Hunold, Johanna Kürschner, Sonia Giraldez Martinez, Preetham Elumalai, Dominic Schmidt, Analia Trevani, Valeria L Runza, Daniela N Männel.   

Abstract

Ficolins activate the lectin pathway of the complement system upon binding to carbohydrate patterns on pathogens. To characterize the producer cells of ficolin-B the expression of mouse ficolin-B, the orthologue of human M-ficolin, was studied in macrophages and dendritic cells during differentiation from bone marrow cells, in primary granulocytes, and during differentiation of granulocytes derived from ER-Hoxb8 cells. Expression of ficolin-B mRNA declined in all myeloid cell types to low levels during terminal differentiation. However, in contrast to macrophages and dendritic cells, ficolin-B expression was enhanced upon activation in granulocytes. High expression of ficolin-B was observed in primary immature neutrophilic CD11b(+) Ly-6C(int) Ly-6G(high) granulocytes when isolated from the bone marrow, in particular during sepsis. Ficolin-B was demonstrated in lysates of primary granulocytes, ER-Hoxb8-derived granulocytes, bone marrow-derived macrophages, and dendritic cells. Native ficolin-B from cell lysates and supernatants of granulocytes activated the lectin pathway as measured by binding to MASP-2 and inducing C4 deposition. Specific staining demonstrated intra-cellular or cell associated ficolin-B protein in activated immature granulocytes deposited in a granular fashion. This study shows that ficolin-B is stored in and set free from immature granulocytic myeloid cells indicating a role in the early infection-induced cellular response of these inflammatory cells.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  BMDC; BMDM; CLP; Complement activation; FcnB; GlcNAc; GlcNAc-BSA; Inflammatory cells; Lectin pathway; MASP; MBL; MBL-associated serine protease; MDSC; N-acetyl glucosamine; N-acetyl glucosamine-coupled BSA; NET; PEC; PMN; bone marrow-derived dendritic cells; bone marrow-derived macrophages; cecal ligation and puncture; ficolin-B; mannan-binding lectin; myeloid cell-derived suppressor cells; neutrophil extracellular trap; peritoneal exudate cells; polymorphonuclear neutrophils

Mesh:

Substances:

Year:  2013        PMID: 23911405     DOI: 10.1016/j.molimm.2013.06.015

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  6 in total

1.  Mannan-binding lectin suppresses growth of hepatocellular carcinoma by regulating hepatic stellate cell activation via the ERK/COX-2/PGE2 pathway.

Authors:  Junru Li; Huifang Li; Yu Yu; Yan Liu; Yunzhi Liu; Qiang Ma; Liyun Zhang; Xiao Lu; Xiang-Yang Wang; Zhengliang Chen; Daming Zuo; Jia Zhou
Journal:  Oncoimmunology       Date:  2018-10-10       Impact factor: 8.110

2.  The inward rectifier potassium channel Kir2.1 is expressed in mouse neutrophils from bone marrow and liver.

Authors:  Ricard Masia; Daniela S Krause; Gary Yellen
Journal:  Am J Physiol Cell Physiol       Date:  2014-12-03       Impact factor: 4.249

Review 3.  Activated Complement Factors as Disease Markers for Sepsis.

Authors:  Jean Charchaflieh; Julie Rushbrook; Samrat Worah; Ming Zhang
Journal:  Dis Markers       Date:  2015-09-02       Impact factor: 3.434

4.  Ficolins do not alter host immune responses to lipopolysaccharide-induced inflammation in vivo.

Authors:  Ninette Genster; Olga Østrup; Camilla Schjalm; Tom Eirik Mollnes; Jack B Cowland; Peter Garred
Journal:  Sci Rep       Date:  2017-06-20       Impact factor: 4.379

Review 5.  Fluid phase recognition molecules in neutrophil-dependent immune responses.

Authors:  Sébastien Jaillon; Andrea Ponzetta; Elena Magrini; Isabella Barajon; Marialuisa Barbagallo; Cecilia Garlanda; Alberto Mantovani
Journal:  Semin Immunol       Date:  2016-03-25       Impact factor: 11.130

Review 6.  Long noncoding RNA: a dazzling dancer in tumor immune microenvironment.

Authors:  Yalu Zhang; Qiaofei Liu; Quan Liao
Journal:  J Exp Clin Cancer Res       Date:  2020-11-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.